Abstract

HIF-1α, an essential transcription factor under hypoxic condition, is indispensable for chondrocytes during skeletal development but its expression and roles in articular chondrocytes are yet to be revealed. We examined HIF-1α protein expression and the hypoxic condition during mouse osteoarthritis (OA) development using state of the art hypoxic probes and found that its expression decreased as OA progressed, coinciding with the change in hypoxic conditions in articular cartilage. Gain- and loss-of-function of HIF-1α in cell culture experiments showed that HIF-1α suppressed catabolic genes such as Mmp13 and Hif2a. We confirmed these anticatabolic effects by measuring glycosaminoglycan release from wild type and conditional knock-out mice femoral heads cultured ex vivo. We went on to surgically induce OA in mice with chondrocyte-specific deletion of Hif1a and found that the development of OA was exacerbated. Increased expression of catabolic factors and activation of NF-κB signalling was clearly evident in the knock-out mice. By microarray analysis, C1qtnf3 was identified as a downstream molecule of HIF-1α, and experiments showed it exerted anti-catabolic effects through suppression of NF-κB. We conclude that HIF-1α has an anti-catabolic function in the maintenance of articular cartilage through suppression of NF-κB signalling.

Details

Title
Hypoxia-inducible factor-1 alpha maintains mouse articular cartilage through suppression of NF-κB signaling
Author
Okada Keita 1 ; Mori Daisuke 2 ; Makii Yuma 1 ; Nakamoto Hideki 1 ; Murahashi Yasutaka 1 ; Yano Fumiko 3 ; Chang Song Ho 1 ; Taniguchi Yuki 1 ; Kobayashi, Hiroshi 1 ; Semba Hiroaki 4 ; Takeda Norihiko 4 ; Piao Wen 5 ; Hanaoka Kenjiro 5   VIAFID ORCID Logo  ; Nagano Tetsuo 6 ; Tanaka Sakae 1 ; Saito Taku 1 

 Sensory & Motor System Medicine, The University of Tokyo, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Sensory & Motor System Medicine, The University of Tokyo, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Bone and Cartilage Regenerative Medicine, The University of Tokyo, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Bone and Cartilage Regenerative Medicine, The University of Tokyo, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Drug Discovery Initiative, The University of Tokyo, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2382997926
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.